Philip Jones
The University of Texas MD Anderson Cancer Center(US)University of Pittsburgh Medical Center(US)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Cancer, Hypoxia, and Metabolism, Receptor Mechanisms and Signaling
Most-Cited Works
- → An inhibitor of oxidative phosphorylation exploits cancer vulnerability(2018)924 cited
- → Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases(2007)571 cited
- → Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials(2023)348 cited
- → Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors(2009)308 cited
- → Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain(2008)303 cited
- → The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies(2015)